Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.

That could be a problem, as the S&P 500 trades at an historically above-average valuation. Today, the S&P 500 index currently ...

One company is set to lead the charge in the next phase of AI development. Artificial intelligence (AI) has been one of the ...

BigBear.ai ( BBAI 3.29%) has been a wildly volatile stock ever since its public debut. The developer of enterprise AI ...

Here's the favorable trend that's boosted the company's stock. As shown in the chart below, Nvidia's data center revenue has ...

Every segment reported higher year-over-year revenue with total sales increasing by 20%. The company's most recent guidance ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...

Social Security's annual cost-of-living adjustments (COLAs) are pegged to inflation. Stubbornly high living costs could lead ...

TSMC offers above-average growth prospects at an average valuation. The shares currently trade at a reasonable forward ...

Many think of Apple as Buffett's largest investment holding for Berkshire Hathaway, but another asset has taken over in the ...

Target generates a lower percentage of its sales from groceries -- which are more resistant to macro headwinds -- than ...

Wall Street's brightest billionaire money managers have mixed feelings about this year's class of companies enacting stock ...